Collectively, LKB1 dysregulation in PCa is primarily driven by non-genetic mechanisms—epigenetic silencing, post-translational modifications, and synergistic interactions with oncogenic pathways such as PTEN loss. Here, STK11 is linked to posterior cortical atrophy.